Retaglutide is a innovative GLP-1 receptor agonist currently under investigation for the management of obesity. This therapy works by stimulating the effects of glucagon-like peptide-1 (GLP-1), a naturally occurring https://prestonliug158131.alltdesign.com/trelaglutide-exploring-a-new-therapy-for-chronic-diseases-57713838